Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Financial Services
Re-evaluating How We Build Life Science Companies for the Next Growth Phase
A candid conversation between DeciBio and The Biotech Builder on why the life sciences industry must innovate not just in science, but in how it finances, hires, and structures companies to build a more resilient future.
October 6, 2025
Blog Article
Financial Services
Re-evaluating How We Build Life Science Companies for the Next Growth Phase
A candid conversation between DeciBio and The Biotech Builder on why the life sciences industry must innovate not just in science, but in how it finances, hires, and structures companies to build a more resilient future.
October 6, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
DeciBio Ventures
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2025
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2025
Next-Generation Therapeutics
Blog Article
Financial Services
Discussion with Svetlana Valonis: Navigating Life Sciences Strategy and M&A in 2025
AI, capital discipline, and smart M&A are reshaping biopharma strategy—DeciBio’s Stephane Budel and advisor Svetlana Valonis break down what’s next.
September 29, 2025
Blog Article
Financial Services
Discussion with Svetlana Valonis: Navigating Life Sciences Strategy and M&A in 2025
AI, capital discipline, and smart M&A are reshaping biopharma strategy—DeciBio’s Stephane Budel and advisor Svetlana Valonis break down what’s next.
September 29, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
DeciBio Ventures
DeciBio Q&A
Clinical Diagnostics
MRD: Market Reflections in Diagnostics - A Conversation with Mark Kaganovich, CEO of Tracer Biotechnologies
We sat down with Mark Kaganovich, CEO of Tracer Biotechnologies, to discuss how Tracer is advancing ctDNA detection and reshaping what’s possible in minimal residual disease (MRD) monitoring.
September 23, 2025
DeciBio Q&A
Clinical Diagnostics
MRD: Market Reflections in Diagnostics - A Conversation with Mark Kaganovich, CEO of Tracer Biotechnologies
We sat down with Mark Kaganovich, CEO of Tracer Biotechnologies, to discuss how Tracer is advancing ctDNA detection and reshaping what’s possible in minimal residual disease (MRD) monitoring.
September 23, 2025
MRD Testing
Blog Article
Research Tools
The Great Diagnostics Tension: Outsourcing vs. Decentralization
In this article, we share our perspective on decentralization based on internal DeciBio databases and tracker, layering the perspective of Joseph Annunziata, a KOL we interview for many of our engagements.
September 22, 2025
Blog Article
Research Tools
The Great Diagnostics Tension: Outsourcing vs. Decentralization
In this article, we share our perspective on decentralization based on internal DeciBio databases and tracker, layering the perspective of Joseph Annunziata, a KOL we interview for many of our engagements.
September 22, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Round-Up 2025
Liquid Biopsy (LBx) continued to develop through August, featuring new product launches and partnerships as well as study results.
September 19, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Round-Up 2025
Liquid Biopsy (LBx) continued to develop through August, featuring new product launches and partnerships as well as study results.
September 19, 2025
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved